FIORE, Vito
 Distribuzione geografica
Continente #
NA - Nord America 2.976
AS - Asia 1.607
SA - Sud America 1.080
EU - Europa 948
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 6.688
Nazione #
US - Stati Uniti d'America 2.893
BR - Brasile 984
SG - Singapore 719
CN - Cina 317
DE - Germania 217
IT - Italia 209
VN - Vietnam 157
HK - Hong Kong 147
FI - Finlandia 110
UA - Ucraina 95
FR - Francia 77
GB - Regno Unito 61
CA - Canada 44
AR - Argentina 39
IN - India 37
TR - Turchia 37
BD - Bangladesh 30
RU - Federazione Russa 28
MX - Messico 23
ZA - Sudafrica 21
ES - Italia 19
IQ - Iraq 19
CZ - Repubblica Ceca 17
PL - Polonia 17
SE - Svezia 17
JP - Giappone 16
EC - Ecuador 14
PK - Pakistan 14
RO - Romania 14
AT - Austria 13
KR - Corea 13
NL - Olanda 13
UZ - Uzbekistan 13
VE - Venezuela 13
KE - Kenya 12
ID - Indonesia 11
AE - Emirati Arabi Uniti 10
LT - Lituania 10
CO - Colombia 9
IL - Israele 9
MA - Marocco 9
NP - Nepal 8
BE - Belgio 7
LB - Libano 7
JO - Giordania 6
PH - Filippine 6
PY - Paraguay 6
DO - Repubblica Dominicana 5
EG - Egitto 5
JM - Giamaica 5
KG - Kirghizistan 5
PE - Perù 5
SA - Arabia Saudita 5
SN - Senegal 5
AL - Albania 4
DZ - Algeria 4
HU - Ungheria 4
PS - Palestinian Territory 4
UY - Uruguay 4
AU - Australia 3
AZ - Azerbaigian 3
CL - Cile 3
KZ - Kazakistan 3
MY - Malesia 3
RS - Serbia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
LU - Lussemburgo 2
MK - Macedonia 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
ET - Etiopia 1
GA - Gabon 1
IE - Irlanda 1
KH - Cambogia 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
SR - Suriname 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TL - Timor Orientale 1
Totale 6.686
Città #
Dallas 1.091
Singapore 430
Chandler 289
San Jose 245
Ashburn 183
Hong Kong 145
Munich 139
New York 130
Beijing 98
Helsinki 79
Los Angeles 72
São Paulo 65
Sassari 58
Princeton 54
Ho Chi Minh City 50
Jacksonville 47
Lauterbourg 46
Rio de Janeiro 36
Hanoi 35
Shanghai 30
Brasília 27
Belo Horizonte 26
Council Bluffs 23
Dearborn 22
Atlanta 21
Denver 21
Santa Clara 21
Brno 17
Montreal 17
Warsaw 17
Campinas 15
Fortaleza 15
Frankfurt am Main 15
Curitiba 14
Nanjing 14
Wilmington 14
Chicago 13
Columbus 13
Guarulhos 13
Orem 13
Seoul 13
Tokyo 13
Toronto 13
Turku 13
Boardman 12
Cagliari 12
Johannesburg 12
Poplar 12
Porto Alegre 12
Salvador 12
Ann Arbor 11
Brooklyn 11
Chennai 11
Falkenstein 11
Houston 11
London 11
Nairobi 11
Rome 11
Sorocaba 11
Izmir 10
Tashkent 10
Da Nang 9
Dhaka 9
Düsseldorf 9
Guayaquil 9
Palermo 9
Stockholm 9
The Dalles 9
Ankara 8
Nanchang 8
Nuremberg 8
Baghdad 7
Buffalo 7
Campo Grande 7
Duque de Caxias 7
Guangzhou 7
Istanbul 7
Mumbai 7
Phoenix 7
Recife 7
Shenyang 7
Americana 6
Amman 6
Brussels 6
Changsha 6
Goiânia 6
Joinville 6
Lahore 6
Lappeenranta 6
Manchester 6
Mountain View 6
San Francisco 6
São José dos Campos 6
São José dos Pinhais 6
Tianjin 6
Turin 6
Washington 6
Woodbridge 6
Amsterdam 5
Bishkek 5
Totale 4.185
Nome #
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 276
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 263
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 218
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 197
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 181
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 174
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 172
Evaluation of EZH2 expression in hepatitis B patients 170
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 166
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 164
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 159
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 159
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 158
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 156
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 143
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 141
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 140
Editorial - Non AIDS-defining malignancies: a new epidemic in HIV-infected population for the upcoming decades? 138
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 136
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 134
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 130
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 129
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 128
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 127
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 127
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 123
Infectious diseases screening approach among refugees: Results from a single-center study 123
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 122
Feasibility and efficacy of eight weeks Glecaprevir/Pibrentasvir to treat incarcerated viremic HCV patients: a case-control study 121
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 120
Tache Noire in a Patient with Acute Q Fever 118
Joint replacement for avascular necrosis in people living with HIV 118
Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019 115
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 115
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 113
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects 111
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 107
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 106
Human urogenital schistosomiasis in West and Sub-Saharan Africa migrants in Sardinia, Italy: A retrospective monocentric study 106
Living with HIV and Getting Vaccinated: A Narrative Review 105
HBV in Italian Women’s Jail: An Underestimated Problem? 100
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 98
The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients 98
HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C 97
Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel 96
The current and future off-label uses of dalbavancin: a narrative review 96
Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE Network 90
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience 86
Health in Prison: Does Penitentiary Medicine in Italy Still Exist? 76
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020 65
Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free 59
SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome 51
Totale 6.821
Categoria #
all - tutte 24.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 25 2 0
2021/2022148 6 3 0 1 1 0 6 8 9 12 37 65
2022/2023503 33 62 13 88 36 77 10 61 66 16 33 8
2023/2024299 29 20 12 10 111 40 13 4 1 1 24 34
2024/20252.133 32 27 96 83 70 88 198 371 638 366 105 59
2025/20263.252 185 688 643 458 427 148 444 53 91 115 0 0
Totale 6.821